Heron Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Heron Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Heron Therapeutics Inc
Rating: 1.07904175
Author: Trendlyne DVM scores

Momentum Trap

about

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, Z...

1.27 0.01 (0.79%)

52.61% Fall from 52W High

1.2M

XNAS Volume

XNAS 08 Jan, 2026 4:30 PM (EST)

Low Financial Strength

16.7 / 100

Expensive Valuation

15.5 / 100

Technically Neutral

37.5 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 254%

4 analysts

Heron Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Heron Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, Z...

52.61% Fall from 52W High

SWOT Analysis

Heron Therapeutics Inc Live Price Chart